Johnson & Johnson
Mega Cap · Healthcare · Drug Manufacturers - General
$273.44+$2.33 (+0.86%)
Johnson & Johnson
Mega Cap · Healthcare · Drug Manufacturers - General
$273.44+$2.33 (+0.86%)
Stock analysis
Get the AI take on JNJ
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$164.23
High$274.90
Today $273.44
RSI (14)
57.3Neutral
03070100
Overall score
55/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Lowest
$190
Current price
$273.44
Median target
$280
Highest
$305
LowHigh
Operating Record
Revenue
What's working
- ROIC: Money put back into the business keeps coming back out as profit, a hallmark of a durable moat.
- ROE: Shareholder capital is compounding at a rate worth paying attention to.
What to watch
- Debt exceeds cash by $28.3B, increasing balance-sheet pressure, a warning sign.
What the market charges
Forward P/E
Middle ground · 8% above avg
23.18x
Price / sales
Reasonable · Priced reasonably against its revenue
6.41x
Price / FCF
Reasonable · Priced a bit rich against its cash flow
28.21x
EV / EBITDA
Reasonable · Operating earnings make this price a stretch but plausible
18.80x
How efficiently it compounds
ROIC
Strong · Comfortably clears the bar for efficient capital use
19.9%
ROE
Favorable · 26.4% - strong capital efficiency
25.7%
Debt / equity
Favorable · 0.68 - solid leverage
0.58x
Current ratio
Reasonable · Just enough on hand to cover near-term bills
1.09x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $627.42B | 30.2 | +8.1% | 55 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |
What is moving JNJ
News
- 2h ago · Trefis
Johnson & Johnson Stock's Independent Streak - Trefis
Mixed - 6h ago · Trefis
Johnson & Johnson Stock: Is the Growth That Makes It Cheaper Believable? - Trefis
Mixed - 10h ago · ad-hoc-news.de
Johnson & Johnson stock pushes toward record highs as Q2 earnings and MedTech win bolster outlook - ad-hoc-news.de
Bullish - 19h ago · TradingView
Johnson & Johnson Stock Jumps 3% as Healthcare Rotation Lifts Shares - TradingView
Bullish 
20h ago · Space Exploration Technologies Corp. via Yahoo Finance
Thinking About Buying SpaceX? These 2 Stocks Should Be Better Bets
Bullish
21h ago · Johnson & Johnson via Nasdaq
Notable Tuesday Option Activity: JNJ, DAL, PWR
Mixed- 1d ago · Johnson & Johnson via Yahoo Finance
Johnson & Johnson (JNJ) Wins FDA Clearance For AI Powered MONARCH QUEST 3
Bullish